Dimensional Fund Advisors’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,547,788
Closed -$27.8M 3389
2017
Q4
$27.8M Buy
1,547,788
+62,628
+4% +$771K 0.01% 1873
2017
Q3
$17.5M Sell
1,485,160
-85,012
-5% -$954K 0.01% 2125
2017
Q2
$16.5M Buy
1,570,172
+15,528
+1% +$158K 0.01% 2120
2017
Q1
$17.1M Sell
1,554,644
-4,789
-0.3% -$55.6K 0.01% 2084
2016
Q4
$21.1M Buy
1,559,433
+103,986
+7% +$1.45M 0.01% 1937
2016
Q3
$17.9M Buy
1,455,447
+40,182
+3% +$474K 0.01% 1997
2016
Q2
$15.5M Sell
1,415,265
-74,222
-5% -$831K 0.01% 2009
2016
Q1
$16.3M Sell
1,489,487
-42,924
-3% -$542K 0.01% 1957
2015
Q4
$26.5M Buy
1,532,411
+106,463
+7% +$1.91M 0.02% 1524
2015
Q3
$28.3M Buy
1,425,948
+169,180
+13% +$3.88M 0.02% 1405
2015
Q2
$20.6M Buy
1,256,768
+230,154
+22% +$3.99M 0.01% 1825
2015
Q1
$16M Buy
1,026,614
+63,491
+7% +$984K 0.01% 1971
2014
Q4
$13.8M Buy
963,123
+64,173
+7% +$678K 0.01% 2054
2014
Q3
$5.84M Sell
898,950
-5,649
-0.6% -$37.5K ﹤0.01% 2480
2014
Q2
$6.24M Buy
904,599
+21,279
+2% +$150K ﹤0.01% 2473
2014
Q1
$6.32M Buy
883,320
+72,251
+9% +$618K ﹤0.01% 2456
2013
Q4
$7.62M Buy
811,069
+4,139
+0.5% +$29.5K 0.01% 2352
2013
Q3
$5.04M Sell
806,930
-2,870
-0.4% -$17.9K ﹤0.01% 2545
2013
Q2
$5.33M Buy
+809,800
New +$6.42M 0.01% 2456

Other funds holding SCMP

Dimensional Fund Advisors's SCMP Position: Q1 2018 in Review

Dimensional Fund Advisors sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 1,547,788 shares — an estimated $27.8M sold.

Dimensional Fund Advisors first reported a position in SCMP in Q2 2013 and held it in 19 quarters. The position peaked at $28.3M in Q3 2015. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Dimensional Fund Advisors reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Dimensional Fund Advisors sold 1,547,788 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $27.8M.
  • Dimensional Fund Advisors first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 19 quarters.
  • Dimensional Fund Advisors's Sucampo Pharmaceuticals, Inc. position peaked at $28.3M in Q3 2015.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Dimensional Fund Advisors's 13F filing for Q1 2018, filed 11 May 2018.